| Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH) M Sałaga, A Mokrowiecka, PK Zakrzewski, A Cygankiewicz, E Leishman, ... Journal of Crohn's and Colitis 8 (9), 998-1009, 2014 | 109 | 2014 |
| Transient receptor potential vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment? J Fichna, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, ... Neurogastroenterology & Motility 24 (11), e557-e560, 2012 | 97 | 2012 |
| Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study J Fichna, JAT Wood, M Papanastasiou, SK Vadivel, P Oprocha, M Sałaga, ... PLoS One 8 (12), e85073, 2013 | 61 | 2013 |
| Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission J Fichna, DP Poole, N Veldhuis, SJ MacEachern, D Saur, PK Zakrzewski, ... Journal of Molecular Medicine 93, 1297-1309, 2015 | 50 | 2015 |
| Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice M Sałaga, U Lewandowska, D Sosnowska, PK Zakrzewski, ... Naunyn-Schmiedeberg's archives of pharmacology 387, 1069-1078, 2014 | 49 | 2014 |
| Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis A Głobińska, M Pawełczyk, A Piechota-Polańczyk, A Olszewska-Ziąber, ... Clinical & Experimental Immunology 187 (1), 100-112, 2017 | 38 | 2017 |
| Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors M Sałaga, PR Polepally, PK Zakrzewski, A Cygankiewicz, M Sobczak, ... Biochemical pharmacology 92 (4), 618-626, 2014 | 38 | 2014 |
| Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases M Sobczak, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, M Sałaga, ... Journal of Pharmacology and Experimental Therapeutics 348 (3), 401-409, 2014 | 29 | 2014 |
| Mitochondrial O-GlcNAc Transferase Interacts with and Modifies Many Proteins and Its Up-Regulation Affects Mitochondrial Function and Cellular Energy … P Jóźwiak, P Ciesielski, PK Zakrzewski, K Kozal, J Oracz, G Budryn, ... Cancers 13 (12), 2956, 2021 | 25 | 2021 |
| Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases M Sobczak, PK Zakrzewski, AI Cygankiewicz, A Mokrowiecka, C Chen, ... Pharmacological Reports 66 (5), 741-750, 2014 | 23 | 2014 |
| Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome M Zielińska, C Chen, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, ... Journal of Pharmacy and Pharmacology 67 (2), 244-254, 2015 | 21 | 2015 |
| TGFβ-pathway is down-regulated in a uterine carcinosarcoma: A case study A Semczuk, PK Zakrzewski, E Forma, AI Cygankiewicz, ... Pathology-Research and Practice 209 (11), 740-744, 2013 | 21 | 2013 |
| Canonical TGFβ signaling and its contribution to endometrial cancer development and progression—underestimated target of anticancer strategies PK Zakrzewski Journal of clinical medicine 10 (17), 3900, 2021 | 19 | 2021 |
| Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for … J Fichna, M Sobczak, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, ... Neurogastroenterology & Motility 26 (11), 1539-1550, 2014 | 19 | 2014 |
| Expression of endoglin in primary endometrial cancer PK Zakrzewski, AI Cygankiewicz, J Mokrosiński, M Nowacka-Zawisza, ... Oncology 81 (3-4), 243-250, 2011 | 18 | 2011 |
| Dysregulation of betaglycan expression in primary human endometrial carcinomas PK Zakrzewski, J Mokrosinski, AI Cygankiewicz, A Semczuk, ... Cancer Investigation 29 (2), 137-144, 2011 | 12 | 2011 |
| Betaglycan Gene (TGFBR3) Polymorphism Is Associated with Increased Risk of Endometrial Cancer PK Zakrzewski, E Forma, AI Cygankiewicz, M Bryś, K Wójcik-Krowiranda, ... Journal of Clinical Medicine 9 (10), 3082, 2020 | 7 | 2020 |
| Significance of TGFBR3 allelic loss in the deregulation of TGFβ signaling in primary human endometrial carcinomas PK Zakrzewski, M Nowacka-Zawisza, A Semczuk, T Rechberger, ... Oncology Reports 35 (2), 932-938, 2016 | 7 | 2016 |
| Zaburzenia kaskady transformujących czynników wzrostu typu β w wybranych patologiach człowieka P Zakrzewski Folia Medica Lodziensia 39 (2), 265-292, 2012 | 3 | 2012 |
| Mitochondrial O-GlcNAc Transferase Interacts with and Modifies Many Proteins and Its Up-Regulation Affects Mitochondrial Function and Cellular Energy Homeostasis. Cancers 2021 … P Józwiak, P Ciesielski, PK Zakrzewski, K Kozal, J Oracz, G Budryn, ... O-GlcNAcylation and Cancer, 79, 2021 | 2 | 2021 |
Adam I. CygankiewiczDepartment of Cytobiochemistry; University of Lodz, Poland在 biol.uni.lodz.pl 的电子邮件经过验证
